Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2321 of 5804
-
CAR-T therapy patients monitored for years in new safety study
Knowledge-focused ENROLLING_BY_INVITATIONThe goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of patients who participated in an AvenCell-sponsored clinical trial and received treatment with AvenCell's UniCAR or RevCAR platforms.
Sponsor: AvenCell Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New graft could make dialysis easier for kidney patients
Disease control Recruiting nowThis study is a single site, prospective, single arm evaluation of the safety and effectiveness of the Healionics STARgraft (10401) hemodialysis access graft. The study is enrolling patients with End Stage Renal Disease (ESRD) requiring hemodialysis via a prosthetic vascular gra…
Phase: NA • Sponsor: Healionics Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for advanced tumors? early trial of IBI3026 begins
Disease control Recruiting nowThis is a multicenter, open-label, phase I dose-escalation and expansion study of IBI3026 in participants with unresectable, locally advanced, or metastatic solid tumors. The study will be conducted in two phases: Phase 1 dose escalation and Phase 2 dose expansion. Safety will be…
Phase: EARLY_PHASE1 • Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can a culturally tailored program help hispanics beat fatty liver disease?
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to understand if a behavioral lifestyle intervention called the Healthy Liver/Hígado Sano program can help Hispanic/Latino patients with metabolic dysfunction associated steatotic liver disease (MASLD), also known as non-alcoholic fatty liver disease …
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for hard-to-treat lymphoma: first human trial of LTZ-301 begins
Disease control Recruiting nowThis study is a first-in-human (FIH), Phase 1, multicenter, open-label study to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and evaluate the preliminary anti-tumor activity of LTZ-301 administered as a single agent in adult subjects with relapsed or re…
Phase: PHASE1 • Sponsor: LTZ Therapeutics, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Experimental pill aims to ease sun sensitivity in rare blood disorder
Disease control Recruiting nowThis is a study to investigate the effect of oral ATL-001 (ciclopirox) in CEP (Congenital Erythropoietic Porphyria) patients. During the study, it will be measured the improvement of skin lesions, fatigue and other clinical symptoms as well as blood parameters. Funding source - F…
Phase: PHASE1, PHASE2 • Sponsor: Atlas Molecular Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill targets Hard-to-Treat cancers with RAS gene flaw
Disease control Recruiting nowThe goal of this clinical trial is to learn determine if AN9025 is safe and tolerable to treat solid cancer tumors with specific genetic mutations. It will help identify doses for use in future testing and establish the safety profile of the drug. The main questions it aims to an…
Phase: PHASE1 • Sponsor: Adlai Nortye Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Full-Body scan may spot hidden inflammation and heart danger
Knowledge-focused Recruiting nowAntineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) is a severe autoimmune condition characterised by inflammation of small blood vessels. The condition causes multi-organ dysfunction and, if left untreated, is usually fatal. AAV is difficult to diagnose and the …
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Can a blood pressure drug curb cocaine cravings?
Symptom relief Recruiting nowThis is a single-center, randomized intervention study in a volunteer population of patients with cocaine/crack use disorder to evaluate the pharmacological treatment of cocaine/crack craving, comparing the drug clonidine with the active placebo clonazepam.
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Earpiece zaps away alcohol withdrawal symptoms?
Symptom relief Recruiting nowThe study will involve a 5-day tAN treatment to attenuate alcohol withdrawal syndrome (AWS) and alter resting state functional connectivity (RSFC) between OFC and striatum in patients with alcohol use disorder (AUD). Enrolled participants will wear the tAN device on-site (at The …
Phase: NA • Sponsor: Spark Biomedical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Brain stimulation may quiet stomach in chronic nausea sufferers
Symptom relief Recruiting nowThe goal of this study is to determine whether stimulation of the brain-stomach connection can influence stomach activity in healthy adults and in individuals suffering from chronic nausea. The main questions it aims to answer are: * What are the best brain sites to influence th…
Phase: NA • Sponsor: David Levinthal • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New virtual program aims to help couples cope with early dementia diagnosis
Symptom relief Recruiting nowThe purpose of the present investigation is to test the efficacy of a virtual, brief (6 sessions) dyadic (patient and care-partner together) intervention to prevent chronic emotional distress in dyads where one person is diagnosed with Young Onset Dementia (YOD). Through this stu…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Shedding pounds to clear skin: new study tests weight loss as psoriasis booster
Symptom relief Not yet recruitingThe goal of this investigator-initiated, real-world, observational study is to investigate the impact of weight loss on treatment efficacy in overweight or obese Chinese patients with moderate-to-severe plaque psoriasis. The main question it aims to answer is: Does a structured…
Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Booster shot for chickenpox: study seeks stronger protection for kids
⭐️ VACCINE ⭐️ Recruiting nowThis study aim to assess the immunogenicity and safety of interchangeable administration of the second dose of varicella vaccine. A total of 300 healthy participants aged 15 months - 12 years will be enrolled. Written informed consent form will be obtained from participants' pare…
Phase: PHASE3 • Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:02 UTC
-
Spleen stiffness scan could spare liver patients painful biopsies
Diagnosis Recruiting nowMeasurement of spleen stiffness (SSM) has shown potential as a complementary tool to liver stiffness measurement (LSM) for the assessment of portal hypertension in patients with MASLD, particularly in the setting of compensated advanced chronic liver disease (cACLD). The 100-Hz p…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Arm cuffs could ease insomnia after stroke, new study hopes
Symptom relief Not yet recruitingThe incidence of post-stroke depression is high, which will affect the rehabilitation of neurological function, damage cognitive function, and increase the risk of subsequent stroke recurrence. The guidelines recommend that in addition to antiplatelet, blood pressure control, lip…
Phase: NA • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Simple ECG may replace extra test for heart device
Knowledge-focused Recruiting nowThe S-ICD defibrillator developed by Boston Scientific Inc. is a fully subcutaneous automatic defibrillation system that prevents and treats sudden cardiac arrest. The subcutaneous system offers the advantage of avoiding the risks associated with transvenous access, limiting seri…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Nerve block may ease pain and fear during skin cancer surgery
Symptom relief Recruiting nowThis study seeks to determine whether adjunct regional nerve blocks reduce pain and anxiety in adult patients undergoing Mohs micrographic surgery for face and scalp skin cancers. Participants will be randomized to one of two arms: (1) placebo regional nerve block with sterile no…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Stem cells from umbilical cords tested for shoulder pain relief
Disease control Recruiting nowThe purpose of this study is to evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients with Rotator Cuff Disease
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New study tests taking migraine pill at earliest warning signs
Symptom relief Recruiting nowMigraine is a neurological disease characterized by moderate or severe headaches, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will assess changes in migraine attack severity for adult participants treating with oral ubrogepant across migrai…
Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC